Bay Colony Advisors’s CONMED CNMD Stock Holding History

Bay Colony Advisors’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-3	Closed	–	–	326
2018 Q2	$0	Buy	+3	New	+$204	﹤0.01%	929

Other funds holding CNMD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

Bay Colony Advisors's CNMD Position: Q3 2018 in Review

Bay Colony Advisors sold out of CONMED (CNMD) in Q3 2018, closing a stake of 3 shares.

Bay Colony Advisors first reported a position in CNMD in Q2 2018 and held it in 1 quarter. The position peaked at $0 in Q2 2018. 207 funds tracked by Wall St. Rank hold CNMD as of Q3 2018.

Bay Colony Advisors reported no remaining CONMED position as of Q3 2018 after selling out during the quarter.
Bay Colony Advisors sold 3 CONMED shares in Q3 2018.
Bay Colony Advisors first reported a position in CONMED in Q2 2018 and held it in 1 quarter.
Bay Colony Advisors's CONMED position peaked at $0 in Q2 2018.
207 funds tracked by Wall St. Rank held CONMED as of Q3 2018.

Based on Bay Colony Advisors's 13F filing for Q3 2018, filed 5 Nov 2018.